Published in Cochrane Database Syst Rev on January 24, 2007
Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes (2012) 1.83
The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol (2010) 1.79
Gut microbiota and inflammation. Nutrients (2011) 1.60
Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol (2008) 1.43
Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. Gastroenterol Res Pract (2011) 1.37
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol (2014) 1.19
Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pediatr Gastroenterol Nutr (2013) 1.18
Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol (2010) 1.11
VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One (2012) 1.02
Probiotics and gut health: a special focus on liver diseases. World J Gastroenterol (2010) 0.96
Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. World J Gastroenterol (2014) 0.96
Innate immune dysfunction in acute and chronic liver disease. Wien Klin Wochenschr (2009) 0.96
Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. Ital J Pediatr (2012) 0.95
Probiotics and Nonalcoholic Fatty liver Disease. Middle East J Dig Dis (2013) 0.88
Liver histology changes in nonalcoholic steatohepatitis after one year of treatment with probucol. Dig Dis Sci (2007) 0.83
Microbiota and nonalcoholic steatohepatitis. Semin Immunopathol (2013) 0.82
Probiotics in hepatology. World J Gastroenterol (2011) 0.82
Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic. Ann Gastroenterol (2012) 0.81
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. Int J Mol Sci (2016) 0.81
Role of the diet as a link between oxidative stress and liver diseases. World J Gastroenterol (2015) 0.80
Gut Microbiota and Lifestyle Interventions in NAFLD. Int J Mol Sci (2016) 0.79
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Int J Mol Sci (2016) 0.78
Pediatric non alcoholic fatty liver disease: more on novel treatment targets. BMC Pediatr (2013) 0.77
The role of the gut microbiome in the pathogenesis and treatment of obesity. Glob Adv Health Med (2014) 0.77
Is there a role for probiotics in liver disease? ScientificWorldJournal (2014) 0.75
The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Nutrients (2017) 0.75
Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. Dig Dis Sci (2015) 0.75
Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration. Nutrition (2017) 0.75
Rapid development of multiple-schedule performances with retarded children. J Exp Anal Behav (1961) 2.90
The Trypanosoma cruzi proteome. Science (2005) 2.63
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med (1997) 1.92
Passionate kissing and microlesions of the oral mucosa: possible role in AIDS transmission. JAMA (1989) 1.54
Leucine and phenylalanine kinetics in compensated liver cirrhosis: effects of insulin. Gastroenterology (1993) 1.50
Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis. Gastroenterology (1996) 1.48
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur J Clin Pharmacol (1993) 1.47
Physiologic effects of pneumoperitoneum. Am J Surg (1994) 1.45
The structures of arabinoxyloglucans produced by solanaceous plants. Carbohydr Res (1996) 1.43
Ultrasound identification of nerve cords in the infraclavicular fossa: a clinical study. Minerva Anestesiol (2012) 1.39
Does pH paper accurately reflect gastric pH? Crit Care Med (1990) 1.39
Laparoscopy in high-risk cardiac patients. Surg Gynecol Obstet (1993) 1.18
Parathyroid cysts. Am J Surg (1982) 1.16
Hepatitis B immunisation with a reduced number of doses in newborn babies and children. Lancet (1985) 1.04
Acute acalculous cholecystitis in the critically ill patient. Am J Surg (1983) 1.03
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev (2007) 1.02
Management and outcome of retroperitoneal abscesses. Ann Surg (1987) 1.02
Two-dose hepatitis B immunisation regimen for infants. Lancet (1985) 1.00
Carcinoma of the stomach after gastric operation. Am J Surg (1981) 1.00
Calculation of the vibration frequencies of alpha-quartz: the effect of Hamiltonian and basis set. J Comput Chem (2004) 0.98
Tandem mass spectrometric analysis of aspergillus niger pectin methylesterase: mode of action on fully methyl-esterified oligogalacturonates. Biochem J (2000) 0.98
SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago). Phytomedicine (1994) 0.97
Differentiating alpha- and beta-aspartic acids by electrospray ionization and low-energy tandem mass spectrometry. Rapid Commun Mass Spectrom (2000) 0.95
Intra-aortic balloon counterpulsation in blunt cardiac injury. J Trauma (1983) 0.94
Effects of single dose of gamma-hydroxybutyric acid and lorazepam on psychomotor performance and subjective feelings in healthy volunteers. Eur J Clin Pharmacol (1999) 0.93
Aberrant presenilin-1 expression downregulates LDL receptor-related protein (LRP): is LRP central to Alzheimer's disease pathogenesis? Mol Cell Neurosci (1999) 0.92
Hydrophilic-interaction chromatography of complex carbohydrates. J Chromatogr A (1994) 0.92
Correlations of relative sensitivities in gas chromatography electron ionization mass spectrometry with molecular parameters. J Am Soc Mass Spectrom (1990) 0.91
Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats. Neuropharmacology (2008) 0.91
Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E. Exp Neurol (2001) 0.91
Laparoscopic appendectomy. A safety and cost analysis. Arch Surg (1993) 0.90
Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine (1999) 0.88
Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev (2007) 0.88
Antepartum diagnosis of pancreatic carcinoma: a case report. Conn Med (1995) 0.87
A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided? Acta Diabetol (2007) 0.87
Blood in saliva of patients with acquired immunodeficiency syndrome: possible implication in sexual transmission of the disease. J Med Virol (1994) 0.87
Probe-immobilized affinity chromatography/mass spectrometry. Anal Chem (1995) 0.87
Selective hepatic arterial embolization of grade IV and V blunt hepatic injuries: an extension of resuscitation in the nonoperative management of traumatic hepatic injuries. J Trauma (1998) 0.87
Fenoldopam to prevent renal replacement therapy after cardiac surgery. Design of the FENO-HSR study. HSR Proc Intensive Care Cardiovasc Anesth (2010) 0.86
Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid. Eur J Clin Pharmacol (1996) 0.86
Simplifying the exoglycosidase digestion/MALDI-MS procedures for sequencing N-linked carbohydrate side chains. Anal Chem (1996) 0.85
A protective role of the low density lipoprotein receptor-related protein against amyloid beta-protein toxicity. J Biol Chem (2000) 0.85
Prognostic value of serum biological markers in patients with hepatocellular carcinoma. Clin Cancer Res (2001) 0.85
Gastric lymphoma: a clinicopathologic reappraisal. Am J Surg (1982) 0.85
Isolated laryngeal leishmaniasis in an immunocompetent patient: a case report. Infez Med (2008) 0.85
New immobilization chemistry for probe affinity mass spectrometry. Rapid Commun Mass Spectrom (1996) 0.84
Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis. Am J Physiol (1994) 0.84
Identification of the glycosylation site and glycan structures of recombinant endopolygalacturonase II by mass spectrometry. Rapid Commun Mass Spectrom (1997) 0.82
Absorption of ciprofloxacin administered through a nasogastric or a nasoduodenal tube in volunteers and patients receiving enteral nutrition. Diagn Microbiol Infect Dis (1990) 0.82
Solid-phase extraction/MALDI-MS: extended ion-pairing surfaces for the on-target cleanup of protein samples. Anal Chem (1999) 0.82
Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin Chem (1994) 0.82
Analysis of the SAGES outcomes initiative cholecystectomy registry. Surg Endosc (2005) 0.82
Oral erosive lichen planus and chronic liver disease. J Am Acad Dermatol (1986) 0.81
Detection of hepatitis C virus-RNA by polymerase chain reaction in dental surgeries. J Med Virol (1995) 0.81
A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease. Neuroscience (1999) 0.81
Laparoscopic treatment of peptic ulcers. A review after 6 years experience with Hill-Barker's procedure. Hepatogastroenterology (1999) 0.81
Performance of six functionals (LDA, PBE, PBESOL, B3LYP, PBE0, and WC1LYP) in the simulation of vibrational and dielectric properties of crystalline compounds. The case of forsterite Mg2SiO4. J Comput Chem (2011) 0.81
Limited acid hydrolysis as a means of fragmenting proteins isolated upon ProteinChip array surfaces. Proteomics (2001) 0.81
The calculation of the vibrational frequencies of crystalline compounds and its implementation in the CRYSTAL code. J Comput Chem (2004) 0.81
Structure of a muramic acid containing capsular polysaccharide from the pathogenic strain of Vibrio vulnificus ATCC 27562. Carbohydr Res (1998) 0.81
Effect of Silibinin on biliary lipid composition. Experimental and clinical study. J Hepatol (1991) 0.80
Acute B viral hepatitis becomes fulminant after infection with hepatitis A virus. Br Med J (Clin Res Ed) (1982) 0.80
Pharmacokinetics of miocamycin in patients with liver cirrhosis. Chemotherapy (1989) 0.80
A desalting approach for MALDI-MS using on-probe hydrophobic self-assembled monolayers. Anal Chem (1997) 0.80
A new matrix for matrix-assisted laser desorption/ionization on magnetic sector instruments with point detectors. Rapid Commun Mass Spectrom (1996) 0.79
Effect of including recommendations for antimicrobial therapy in microbiology laboratory reports. Diagn Microbiol Infect Dis (1991) 0.79
Fragmentation studies of peptides: the formation of y ions. Rapid Commun Mass Spectrom (1992) 0.79
Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis. Am J Physiol Endocrinol Metab (2002) 0.78
On-probe solid-phase extraction/MALDI-MS using ion-pairing interactions for the cleanup of peptides and proteins. Anal Chem (1998) 0.78
Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis. Int J Clin Pharmacol Ther Toxicol (1984) 0.78
Hand-assisted laparoscopic management of liver tumors. Surg Endosc (2007) 0.78
Characterization of the glycosylation of recombinant endopolygalacturonase I from Aspergillus niger. Rapid Commun Mass Spectrom (1999) 0.78
An endogenous sulfated inhibitor of neuronal inositol trisphosphate receptors. Biochemistry (2000) 0.78
Enteral nutrition: should we feed the stomach? Crit Care Med (1999) 0.78
On-target exoglycosidase digestions/MALDI-MS for determining the primary structures of carbohydrate chains. Anal Chem (1999) 0.77
Optimization of a hydrophobic solid-phase extraction interface for matrix-assisted laser desorption/ionization. J Mass Spectrom (1998) 0.77
Identifying the glycosylation sites and site-specific carbohydrate heterogeneity of glycoproteins by matrix-assisted laser desorption/ ionization mass spectrometry. Rapid Commun Mass Spectrom (1996) 0.77
Ultrasonographic findings of testicular microlithiasis associated with intratubular germ cell neoplasia. Urology (1991) 0.77
The vibration properties of the (n,0) boron nitride nanotubes from ab initio quantum chemical simulations. J Chem Phys (2013) 0.77
Validity of laparoscopy after abdominal surgery. Endoscopy (1987) 0.77
Sexual transmission of hepatitis C virus and prevention with intramuscular immunoglobulin. AIDS Patient Care STDS (1998) 0.77
An evaluation of bilirubin kinetics with respect to the diagnosis of Gilbert's syndrome. Clin Sci Mol Med (1978) 0.77
Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief. Health Technol Assess (2011) 0.76
Epidemiology of unconjugated hyperbilirubinemia: revisited. Semin Liver Dis (1988) 0.76
The effect of drugs on bile flow and composition. An overview. Drugs (1986) 0.76
Continuous mixed venous oximetry in critically ill surgical patients. 'High-tech' cost-effectiveness. Arch Surg (1986) 0.76
Prevalence of hepatitis C virus genotypes in southern Italy. Eur J Epidemiol (1997) 0.76
Laparoscopy and guided liver biopsy in the diagnosis of cirrhosis: conventional technique vs. minilaparoscopy. Endoscopy (2003) 0.76
Quality of life in intensive care unit survivors: a place for outcomes research in critical care. Crit Care Med (2000) 0.75
Congenital anomalies of the liver: laparoscopic observations. Gastrointest Endosc (2000) 0.75
Laparoscopy in chronic renal failure. Gastrointest Endosc (1998) 0.75
Risk of breast cancer in carriers of BRCA gene mutations. N Engl J Med (1997) 0.75
Gastrointestinal motility and tube feeding. Crit Care Med (1998) 0.75
Pharmacokinetic studies of famotidine in patients with liver cirrhosis. Am J Gastroenterol (1992) 0.75
Peptic ulcer disease and thoracoscopic left truncal vagotomy. JSLS (1999) 0.75
Re: S. Iwarson: new vaccines against hepatitis A enter the market--but who should be vaccinated? (Infection 20 [1992] 192-193) Infection (1993) 0.75
Fast atom bombardment mass spectrometry of carbohydrates contaminated with inorganic salts using a crown ether. J Mass Spectrom (1998) 0.75